Scopus Now Available in Research4Life for Scientists in the Developing World

Scientists in developing world benefit from freely available web-integrated literature research tool with citation information, direct links to full-text articles, library resources, patent searches and reference management software

Amsterdam, 2 December 2009 – Elsevier, a world-leading publisher of scientific, technical and medical information products and services, today announced that Scopus, the largest abstract and citation database of peer-reviewed literature and quality Web sources, will be added to Research4Life, Scopus contains abstracts and references from nearly 18,000 peer reviewed journals from more than 5,000 international publishers.

Research4Life is the collective name given to HINARI, AGORA and OARE, the three public-private partnerships that offer health, agriculture and environmental research for free or at very low cost to developing countries. Key partners include WHO, FAO, UNEP, Cornell and Yale Universities, the International Association of Scientific, Technical and Medical Publishers and technology partner, Microsoft,. Over 150 publishers, among them Elsevier, Springer, Wiley-Blackwell and Oxford University Press provide their journal content.

"Developing country researchers need evidence to ensure they are pursuing the most relevant topics for their research. Without high-caliber search tools, that evidence remains hidden. HINARI is delighted that our users will have such a wonderful opportunity with Scopus to discover what is being published in their areas of interest,” remarked Kimberly Parker, HINARI Program Manager at the WHO.

“We are very pleased to offer Scopus to scientists in the developing world who may not otherwise be able to benefit from this versatile resource,” commented Niels Weertman, Director Scopus, Performance & Planning at Elsevier in the Academic & Government Products Group. “This initiative is very much in line with Scopus’ mission to contribute to the advancement of science.”

# # #

About Research4Life
Research4Life is the collective name for three public-private partnerships which seek to help achieve the UN’s Millennium Development Goals by providing the developing world with access to critical scientific research. Since 2002, the three programmes, Health Access to Research (HINARI), Access to Global Online Research in Agriculture (AGORA) and Online Access to Research in the Environment (OARE), have given researchers at more than 5,000 institutions in 108 developing world countries free or low cost access to over 7,000 journals provided by the world’s leading science publishers.
Research4Life is a public-private partnership of the WHO, FAO, UNEP, Cornell and Yale Universities and the International Association of Scientific, Technical and Medical Publishers. Together with technology partner Microsoft, the partnership’s goal is to help attain six of the UN’s eight Millennium Development Goals by 2015, reducing the scientific knowledge gap between industrialized countries and the developing world.

For further information please visit www.Research4Life.org or view the Research4Life YouTube channel.

About Scopus
Covering the world’s research literature, Scopus is the largest abstract and citation database of peer-reviewed literature and quality Web sources with smart tools to track analyze and visualize research. Scopus was designed and developed with over 500 users and librarians internationally. Its unique database contains abstracts and references from nearly 18,000 titles from more than 5,000 international publishers, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers users citation information about the articles covered, but also directly integrates Web and patent searches. Direct links to full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool. For more information about Scopus please visit www.info.scopus.com.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contacts:
Shira Tabachnikoff
Elsevier
+ 31 20 485 2736
s.tabachnikoff@elsevier.com